| Product Code: ETC12954414 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Multiplexed Diagnostics Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Multiplexed Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Multiplexed Diagnostics Market - Industry Life Cycle |
3.4 Ireland Multiplexed Diagnostics Market - Porter's Five Forces |
3.5 Ireland Multiplexed Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Multiplexed Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Multiplexed Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Ireland Multiplexed Diagnostics Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.9 Ireland Multiplexed Diagnostics Market Revenues & Volume Share, By Detection Method, 2021 & 2031F |
4 Ireland Multiplexed Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Ireland, leading to higher demand for multiplexed diagnostics. |
4.2.2 Technological advancements in the field of diagnostics, making multiplexed testing more efficient and cost-effective. |
4.2.3 Rising awareness among healthcare professionals and patients about the benefits of multiplexed diagnostics in providing accurate and timely results. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of multiplexed diagnostic tests, leading to longer time-to-market. |
4.3.2 Limited reimbursement policies for multiplexed diagnostics, affecting affordability for patients and adoption by healthcare providers. |
5 Ireland Multiplexed Diagnostics Market Trends |
6 Ireland Multiplexed Diagnostics Market, By Types |
6.1 Ireland Multiplexed Diagnostics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Ireland Multiplexed Diagnostics Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Microarray-Based, 2021 - 2031F |
6.1.5 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Bead-Based, 2021 - 2031F |
6.1.6 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Cell-Based, 2021 - 2031F |
6.1.7 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Point-of-Care, 2021 - 2031F |
6.2 Ireland Multiplexed Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Infectious Disease, 2021 - 2031F |
6.2.3 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.4 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Autoimmune Disorders, 2021 - 2031F |
6.2.5 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.2.6 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.3 Ireland Multiplexed Diagnostics Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Digital PCR, 2021 - 2031F |
6.3.3 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Microfluidics, 2021 - 2031F |
6.3.4 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Immunoassays, 2021 - 2031F |
6.3.5 Ireland Multiplexed Diagnostics Market Revenues & Volume, By NGS, 2021 - 2031F |
6.3.6 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Biosensors, 2021 - 2031F |
6.4 Ireland Multiplexed Diagnostics Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Plasma, 2021 - 2031F |
6.4.4 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.5 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Urine, 2021 - 2031F |
6.4.6 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.5 Ireland Multiplexed Diagnostics Market, By Detection Method |
6.5.1 Overview and Analysis |
6.5.2 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Fluorescence, 2021 - 2031F |
6.5.3 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Luminescence, 2021 - 2031F |
6.5.4 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Chemiluminescence, 2021 - 2031F |
6.5.5 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Colorimetric, 2021 - 2031F |
6.5.6 Ireland Multiplexed Diagnostics Market Revenues & Volume, By Multiplex PCR, 2021 - 2031F |
7 Ireland Multiplexed Diagnostics Market Import-Export Trade Statistics |
7.1 Ireland Multiplexed Diagnostics Market Export to Major Countries |
7.2 Ireland Multiplexed Diagnostics Market Imports from Major Countries |
8 Ireland Multiplexed Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of multiplexed diagnostics by healthcare facilities in Ireland. |
8.2 Average turnaround time for multiplexed diagnostic test results. |
8.3 Number of research collaborations between diagnostic companies and healthcare institutions in developing innovative multiplexed tests. |
8.4 Percentage increase in the number of approved multiplexed diagnostic tests in the market. |
9 Ireland Multiplexed Diagnostics Market - Opportunity Assessment |
9.1 Ireland Multiplexed Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Multiplexed Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Multiplexed Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Ireland Multiplexed Diagnostics Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.5 Ireland Multiplexed Diagnostics Market Opportunity Assessment, By Detection Method, 2021 & 2031F |
10 Ireland Multiplexed Diagnostics Market - Competitive Landscape |
10.1 Ireland Multiplexed Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Ireland Multiplexed Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here